US5844076AExpiredUtility

Totally synthetic affinity reagents

55
Assignee: UNIV NORTH CAROLINAPriority: Feb 15, 1990Filed: Jun 6, 1995Granted: Dec 1, 1998
Est. expiryFeb 15, 2010(expired)· nominal 20-yr term from priority
C07K 16/3007C07K 16/44C07K 14/47C07K 2319/73C07K 2319/72C07K 2319/705C07K 16/00C07K 2319/50C07K 2319/735C12N 15/1037C07K 2319/00C07K 2319/20C12N 15/1075C12N 15/1048C12N 15/70C40B 40/02C07K 16/3069C07K 16/18C12N 15/1062C12N 15/62C07K 2319/61C07K 2317/34C07K 16/40
55
PatentIndex Score
5
Cited by
329
References
3
Claims

Abstract

A method for producing heterofunctional binding fusion proteins termed Totally Synthetic Affinity Reagents (TSARs) is disclosed. TSARs are concatenated heterofunctional proteins, polypeptides or peptides comprising at least two functional regions: a binding domain with affinity for a ligand and a second effector peptide portion that is chemically or biologically active. In one embodiment, the heterofunctional proteins, polypeptides or peptides further comprise a linker peptide portion between the binding domain and the second active peptide portion. The linker peptide can be either susceptible or not susceptible to cleavage by enzymatic or chemical means. Heterofunctional binding reagents as well as methods for using the reagents for a variety of in vitro and in vivo applications are also disclosed.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A peptide which binds specifically to calmodulin and consisting of the amino acid sequence of SEQ ID NO 135. 
     
     
       2. A peptide which binds specifically to calmodulin, and consisting of an amino acid sequence which contains one or more substituted amino acids relative to the sequence of SEQ ID NO 135, in which each substituted amino acid is selected from a class of amino acids of similar polarity to the amino acid residue replaced by the substituted amino acid in SEQ ID NO 135. 
     
     
       3. A protein which binds specifically to calmodulin, and comprising the amino acid sequence of SEQ ID NO 135.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.